Market Cap 62.34M
Revenue (ttm) 81.67M
Net Income (ttm) -55.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -67.80%
Debt to Equity Ratio -12.99
Volume 119,500
Avg Vol 527,200
Day's Range N/A - N/A
Shares Out 49.88M
Stochastic %K 55%
Beta 1.34
Analysts Hold
Price Target $2.51

Latest News on AKYA

Akoya Biosciences Reports First Quarter 2025 Financial Results

May 12, 2025, 4:05 PM EDT - 23 days ago

Akoya Biosciences Reports First Quarter 2025 Financial Results


Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 9:43 PM EST - 7 months ago

Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript


Akoya Biosciences Reports Third Quarter 2024 Financial Results

Nov 14, 2024, 4:00 PM EST - 7 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results


Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 10:19 PM EDT - 10 months ago

Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript


Akoya Biosciences Reports Second Quarter 2024 Financial Results

Aug 5, 2024, 4:00 PM EDT - 10 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results


Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Dec 7, 2023, 7:45 AM EST - 1 year ago

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock


Akoya Biosciences, Inc. (AKYA) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 12:49 AM EST - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q3 2023 Earnings Call Transcript